Download Free Medical Urticaria and Angioedema 101 PowerPoint Presentation

Urticaria and Angioedema 101 PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : This medical presentation titled ""Urticaria and Angioedema 101"" is a case presentation on urticaria and angioedema.

Tags : Allergy, Urticaria, Angioedema, Urticaria, Raised, erythematous, blanching, Pruritic, Lesions, Subcutaneous swelling, Predilection, connective tissue, face, mucus membranes, Hives, Mediators, etiologies, Aeroallergens, pollens, management, PHARMACOTHERAPY, Immunomodulatory agents, Cyclosporine

Published on : Apr 24, 2021 | Views : 3539 | Downloads : 17

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Urticaria and Angioedema 101 Scot Laurie, MD Allergy and Asthma Center at NorthPark Assistant professor, University of Texas Southwestern Medical Center
Slide 2-

Case Presentation Jim S. is a 45 y/o who presented for evaluation of his urticaria. He has been suffering with hives for the past 4 months. He is unable to tell what triggers his hives. His hives are generalized and an individual hive will last a few hours; he has had several episodes of lip swelling as well. He might have had a similar episode 10 years ago and his doctor told him he was allergic to penicillin
Slide 3-

Case presentation He has visited his primary care physician who suggested he take Claritin He returned when his hives persisted and the doctor told him that he was allergic to something and suggested an allergy evaluation.
Slide 4-

Case presentation Past medical history Hypothyroidism Medications levothyroxine Ibuprofen prn Review of systems Occasional headaches; otherwise negative Physical exam
Slide 5-

ppt slide no 5 content not found
Slide 6-

Case presentation How would his hives be classified? What is causing his hives? Are his medical conditions or medications contributing to his hives? What tests should be done to evaluate his hives? How are his hives best treated?
Slide 7-

URTICARIA & ANGIOEDEMA DESCRIPTION Urticaria Raised, erythematous, blanching Pruritic Lesions well-circumscribed; typically coalesce Angioedema Subcutaneous swelling Predilection to areas of loose connective tissue, such as the face or mucus membranes involving the lips or the tongue
Slide 8-

ppt slide no 8 content not found
Slide 9-

Urticaria or “Hives”
Slide 10-

ppt slide no 10 content not found
Slide 11-

Urticaria and Angioedema Clinical features: Urticaria Repeated occurrence of short-lived cutaneous wheals accompanied by erythema and pruritus Wheals range in size from a few millimeters to several centimeters Wheals may coalesce to form larger lesions Individual wheals typically last less than 24 hours Urticaria may occur anywhere on the skin Mucus membrane involvement is rare Lesions should resolve without any residual marking
Slide 12-

Urticaria and Angioedema Clinical features: Angioedema Approximately 50% of patients with chronic urticaria have angioedema as well Episodes of short-lived deep dermal and subcutaneous or submucosal edema Like urticaria, symptoms generally last less than 24 hours Larger swellings may take longer to resolve Pruritus does not consistently accompany angioedema, and may not occur at all.
Slide 13-

Mediators of hives and swelling
Slide 14-

Urticaria and Angioedema Classification Acute: < 6 weeks Allergic Infectious Idiopathic Recurrent acute Chronic: > 6 weeks Idiopathic Autoimmune Physical
Slide 15-

URTICARIA CLASSIFICATION Acute: < 6 weeks Affects as many as 10-20% of the population at some point in their lives Etiology frequently identified Food allergy Drug allergy Stings/venoms Infection Viral infection leading cause of urticaria in children
Slide 16-

Urticaria Classification Recurrent acute (intermittent) Episodes of urticaria lasting days or weeks with intervals of days, weeks, or months in between episodes Chronic: > 6 weeks Idiopathic Physical urticarias
Slide 17-

URTICARIA ETIOLOGIES Common Idiopathic Medications Stings Foods Infection Physical urticarias Rare Causes Neoplasms Collagen vascular disease Endocrine Urticarial vasculitis
Slide 18-

Urticaria etiologies Urticaria is rarely, if ever the presenting or sole symptom of an underlying disease A complete Review of Systems will suggest or identify any systemic disease in which the urticaria occurs
Slide 19-

URTICARIA ETIOLOGIES Medications Any drug has the potential to elicit an allergic reaction Antibiotics in general, and penicillins specifically, are most often indicated Aspirin/NSAID’s Considered second most common cause of acute drug allergic reactions Frequently exacerbate chronic urticaria and angioedema
Slide 20-

URTICARIA ETIOLOGIES Foods Important cause of acute urticaria Primary allergens are peanuts, tree nuts, shellfish, fish, eggs, milk Chronic urticaria typically unrelated to food allergy Infection Common cause of acute urticaria Viral infection most common cause in children Episodes are self-limited Rare cause of chronic urticaria
Slide 21-

INSECT BITES & STINGS Generalized urticaria/angioedema Indicates systemic reaction Requires allergist evaluation for possible immunotherapy Urticaria in children does not require immunotherapy Hymenoptera bees, wasps, yellow jackets, hornets Fire ants
Slide 22-

URTICARIA ETIOLOGIES Aeroallergens Rarely, if ever, cause urticaria Animals may cause contact urticaria Inhaled latex may result in systemic allergic reaction ? seasonal pollens Contact Urticaria Nonimmunologic cinnamic acid, benzoic acid Diagnosed by open patch test Immunologic (Allergic) Latex, fruits, vegetables Diagnosed by applying material to eczematous or scratched skin
Slide 23-

Urticaria etiologies Endocrine/autoimmune Thyroid disease Urticaria and angioedema has been associated with hypo- and hyperthyroidism Possible association with the presence of thyroid autoantibodies (antithyroid peroxidase and antithyroglobulin) Thyroid autoimmunity has been demonstrated in 12-26 % of subjects with chronic urticaria Thyroid autoimmunity occurs in 3-6% of the population
Slide 24-

URTICARIA ETIOLOGIES Chronic urticaria Most common etiology is idiopathic 30-60% of patients exhibit a wheal-and-flare with autologous serum skin testing Thought to be due to a complement-activating, histamine-releasing autoantibody (IgG) against the α-chain of the high-affinity IgE receptor (FcεRI) These autoantibodies are able to trigger mast cell or basophil histamine release through direct crosslinking of adjacent receptors Can cause histamine release in healthy subjects Treatment implications: urticaria may be more difficult to control
Slide 25-

Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions more frequently than autologous serum J Allergy Clin Immunol 2006;117:1113-7.
Slide 26-

Chronic urticaria: etiologies 51/96 (53%) patients had positive ASST 61/71 (86%) patients had positive APST Prothrombin fragment F(1+2) (marker of thrombin generation) was higher in patients than in controls Levels directly related to severity of urticaria
Slide 27-

Chronic urticaria: etiologies Conclusions Suggests role of the activation of the extrinsic coagulation pathway with thrombin generation in chronic urticaria Thrombin increases vascular permeability (edema) May trigger mast cell degranulation Possible therapeutic use of anticoagulants (heparin/warfarin)
Slide 28-

Natural history: Chronic Urticaria Up to 50% patients resolve within 3-12 months Another 20% of patients resolve in 12-36 months or 36-60 months Up to 1.5% of patients persist for 20+ years 50% of patients with chronic urticaria will have recurrences Physical urticarias tend to last longer, as do more severe forms of chronic urticaria
Slide 29-

PHYSICAL URTICARIAS Symptomatic dermographism Cholinergic Delayed pressure Cold Aquagenic Solar Vibratory adrenergic
Slide 30-

PHYSICAL URTICARIAS Dermographism Very common- affects 2-5% of population Small fraction of these patients will seek treatment Stroking of the skin results in linear wheals which may persist as long as 30 minutes patients may complain of generalized pruritus or “skin crawling”
Slide 31-

ppt slide no 31 content not found
Slide 32-

PHYSICAL URTICARIAS Cholinergic urticaria Likely the most common of the physical urticarias- 30% of the physical urticarias Occurs primarily in teenagers and young adults Pruritic, small macules and papules occur in response to heat, exercise, or emotional stress May occur with wheezing May occur without visible skin lesions (cholinergic pruritus)
Slide 33-

ppt slide no 33 content not found
Slide 34-

Physical urticarias Cold urticaria Characterized by the rapid onset of pruritus, erythema, and swelling after exposure to a cold stimulus Holding cold objects: hand swelling Eating cold items: lip swelling/ oropharyngeal edema Swimming, with total body immersion, can result in massive mediator release, resulting in hypotension Risk factor: oral symptoms with ingestion of cold items
Slide 35-

ppt slide no 35 content not found
Slide 36-

ppt slide no 36 content not found
Slide 37-

URTICARIA EVALUATION Acute urticaria and angioedema History to ascertain for possible triggers: food, drug, sting, infection Exam to confirm diagnosis May refer to board-certified allergist for select skin testing/challenge tests to suspected agents
Slide 38-

Urticaria evaluation Chronic urticaria History and physical exam Confirm diagnosis of urticaria/angioedema Laboratory studies Usually none required No relationship has been found between the number of identified diagnoses and the number of laboratory tests performed Consider thyroid evaluation (TSH, thyroid autoantibodies) in patients who fail initial therapy If urticarial vasculitis suspected: ANA, complement levels Referral for skin biopsy
Slide 39-

Skin biopsy Indications Individual urticarial lesion persists for >48 hours Urticaria are less than moderately pruritic Lack of significant response to “maximum” doses of antihistamines
Slide 40-

URTICARIA MANAGEMENT Goals control symptoms & keep patient comfortable search for and treat underlying etiologies exclude serious diseases Avoidance causative factor if identified NSAID’s & ASA excessive heat Supportive therapy Reassurance Patient education is most important
Slide 41-

Urticaria management Chronic idiopathic urticaria Because there is no one specific causative agent that can be withdrawn, the hives cannot be “cured”. Treatment is considered palliative, until the condition resolves on its own Goal is to maintain a patient’s quality of life, despite condition
Slide 42-

INITIAL URTICARIA PHARMACOTHERAPY Antihistamines: H1 receptor antagonists Second generation (“Non-sedating”) equal in efficacy to first generation without as many side effects cetirizine, levocetirizine, desloratadine, fexofenadine, loratadine First generation Generally administered on a daily basis for preventative therapy hydroxyzine, diphenhydramine, chlorpheniramine, etc. dose at qhs initially to reduce daytime somnolence May be used on a prn basis
Slide 43-

SECONDARY URTICARIA PHARMACOTHERAPY H2 antagonists 15% of histamine receptors in the skin are H2 May use in combination with H1 antagonists Inhibits metabolism of hydroxyzine, resulting in higher plasma concentration of hydroxyzine Doxepin Very potent H1 antagonist H2 antagonist as well May be very sedating- generally use at night Leukotriene antagonists Zafirlukast and montelukast superior to placebo in the treatment of chronic urticaria
Slide 44-

Urticaria management Antihistamine “cocktail” Begin with 2nd generation antihistamine once a day; if response unsatisfactory, Double the dose (either split-dose twice daily, or full dose once daily); if response unsatisfactory, ADD Doxepin 10-50 qhs (titrate over time to reduce sedation) Levocetirizine/cetirizine>fexofenadine>desloratadine/ loratadine
Slide 45-

SECONDARY URTICARIA PHARMACOTHERAPY Oral corticosteroids Role of systemic steroids in the treatment of chronic urticaria is limited Short-term use in special situations (e.g. control of symptoms prior to an important event.) Prolonged treatment complicated by severe side effects along with worsening of urticaria upon withdrawal
Slide 46-

Alternative agents for refractory chronic urticaria Drug Level of evidence Leukotriene modifiers Ib Dapsone IIb Sulfasalazine III Hydroxychloroquine Ib Colchicine III Calcineurin inhibitors Ib Mycophenolate IIb Omalizumab III
Slide 47-

SECONDARY URTICARIA PHARMACOTHERAPY Immunomodulatory agents Limited studies demonstrate efficacy of cyclosporine in improving urticaria along with decreasing dependence on prednisone. Suppressive effect on basophil and mast cell activation Requires monitoring of a patient’s blood pressure and renal function
Slide 48-

Cyclosporine Patients with chronic, severe urticaria with positive autologous skin test 3-month course of treatment resulted in 80% totally or almost clearing their symptoms Upon medication withdrawal at 3 months: 1/3 remained clear 1/3 relapsed mildly 1/3 relapsed to baseline Br J Dermatol 2000;143:368.
Slide 49-

Urticaria and angioedema Pearls Urticaria and angioedema frequently is not an allergic condition Urticaria does not respond to topical treatment Urticaria in the setting of antibiotics use might be due to the infection, rather than the antibiotic Almost all urticaria is responsive to antihistamines; if your initial dose does not work, use more When all else fails, refer to your favorite fellowship-trained allergy and immunology specialist Treatment references: N Engl J Med 2002;346:175-9 or Allergy and Asthma Proc 2004;25:143-149.
Slide 50-

I Need an Allergist!!